Chemed (CHE) Total Non-Current Liabilities (2009 - 2026)

Chemed has reported Total Non-Current Liabilities for 18 years, with the latest figure at $674.3 million in Q1 2026.

• For the quarter ending Q1 2026, Total Non-Current Liabilities rose 26.82% year-over-year to $674.3 million; the trailing twelve-month figure through Mar 2026 stood at $674.3 million (up 26.82% YoY), and the FY2025 full-year result was $545.4 million, up 1.72% from the prior year.
• Total Non-Current Liabilities for Q1 2026 stood at $674.3 million, up from $545.4 million in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $674.3 million in Q1 2026, with the low at $506.1 million in Q2 2025.
• Average Total Non-Current Liabilities over 5 years is $561.7 million, with a median of $538.6 million recorded in 2023.
• Year-over-year, Total Non-Current Liabilities grew 27.05% in 2022 and retreated 14.97% in 2023.
• Tracing CHE's Total Non-Current Liabilities over 5 years: stood at $631.2 million in 2022, then decreased by 13.3% to $547.2 million in 2023, then dropped by 2.01% to $536.2 million in 2024, then increased by 1.72% to $545.4 million in 2025, then rose by 23.62% to $674.3 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $674.3 million (Q1 2026), $545.4 million (Q4 2025), and $533.6 million (Q3 2025), per Business Quant data.

Peer Comparison